|Client||US-based emerging biotech
Scope – Global, focus on EU
|Company Objectives||Establish and support EU price level and reimbursement implementation.
Overcome identified obstacles to maximize return on the compound and maintain narrow price corridor .
|Project Description||Help management to design and execute a series of interlocking P&R and market access imperatives. These include:
Ensure alignment in goals and implementation activities to support them while “translating” between HQ and local European managers.
|Project Outcome||All P&R goals have been exceeded or met to date and company profitability targets exceeded.
Rollout into “second wave” of counties is continuing successfully.